MediNet Group Past Earnings Performance
Past criteria checks 0/6
MediNet Group's earnings have been declining at an average annual rate of -9.4%, while the Healthcare industry saw earnings growing at 5.1% annually. Revenues have been declining at an average rate of 5.3% per year.
Key information
-9.4%
Earnings growth rate
-9.4%
EPS growth rate
| Healthcare Industry Growth | 11.3% |
| Revenue growth rate | -5.3% |
| Return on equity | -302.7% |
| Net Margin | -24.7% |
| Last Earnings Update | 30 Sep 2023 |
Revenue & Expenses BreakdownBeta
How MediNet Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 23 | 110 | -27 | 1 | 0 |
| 30 Jun 23 | 111 | -26 | 2 | 0 |
| 31 Mar 23 | 110 | -25 | 2 | 0 |
| 31 Dec 22 | 106 | -10 | 2 | 0 |
| 30 Sep 22 | 113 | -6 | 2 | 0 |
| 30 Jun 22 | 118 | -6 | 1 | 0 |
| 31 Mar 22 | 121 | -6 | 1 | 0 |
| 31 Dec 21 | 128 | -2 | 0 | 0 |
| 30 Sep 21 | 130 | 1 | 0 | 0 |
| 30 Jun 21 | 130 | 4 | 1 | 0 |
| 31 Mar 21 | 129 | 5 | 1 | 0 |
| 31 Dec 20 | 131 | -5 | 2 | 0 |
| 30 Sep 20 | 133 | -8 | 1 | 0 |
| 30 Jun 20 | 137 | -13 | 2 | 0 |
| 31 Mar 20 | 145 | -15 | 2 | 0 |
| 31 Dec 19 | 152 | -10 | 5 | 0 |
| 30 Sep 19 | 156 | -10 | 8 | 0 |
| 30 Jun 19 | 157 | -12 | 10 | 0 |
| 31 Mar 19 | 141 | -13 | 13 | 0 |
| 31 Dec 18 | 127 | -12 | 12 | 0 |
| 30 Sep 18 | 111 | -14 | 11 | 0 |
| 30 Jun 18 | 97 | -15 | 11 | 0 |
| 31 Mar 18 | 98 | -13 | 10 | 0 |
| 31 Dec 17 | 100 | -11 | 10 | 0 |
| 30 Sep 17 | 100 | -7 | 9 | 0 |
| 30 Jun 17 | 98 | -4 | 7 | 0 |
| 31 Mar 17 | 99 | -4 | 7 | 0 |
| 31 Dec 16 | 100 | -1 | 6 | 0 |
| 30 Sep 16 | 99 | -3 | 5 | 0 |
| 30 Jun 16 | 98 | -2 | 5 | 0 |
| 31 Mar 16 | 94 | -2 | 4 | 0 |
| 31 Dec 15 | 94 | 2 | 4 | 0 |
| 31 Mar 15 | 89 | 11 | 4 | 0 |
| 31 Mar 14 | 78 | 6 | 4 | 0 |
Quality Earnings: 8161 is currently unprofitable.
Growing Profit Margin: 8161 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 8161 is unprofitable, and losses have increased over the past 5 years at a rate of 9.4% per year.
Accelerating Growth: Unable to compare 8161's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 8161 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (13.4%).
Return on Equity
High ROE: 8161 has a negative Return on Equity (-302.69%), as it is currently unprofitable.